drugset / Trial / NCT00634348
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to compare the efficacy and safety of ziprasidone and aripiprazole in hospitalized patients with schizophrenia or schizoaffective disorder
Timeline
- Start
- 2004-04
- Primary completion
- —
- Completion
- 2005-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aripiprazole | Other / unclassified | 10 mg | Oral |
| Comparator | Aripiprazole | Other / unclassified | 15 mg | Oral |
| Comparator | Aripiprazole | Other / unclassified | 30 mg | Oral |
| Comparator | Ziprasidone | Small molecule | 40 mg | Oral |
| Comparator | Ziprasidone | Small molecule | 60 mg | Oral |
| Comparator | Ziprasidone | Small molecule | 80 mg | Oral |